W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies

X

Council for Tariffs Affairs

24 January, 2023

The Meeting of the Tariffs Council No. 3/2023 of 26.01.2023

16 January, 2023

Communication on the Tariff Council meeting on 12 January 2023.

13 January, 2023

The Meeting of the Tariffs Council No. 2/2023 of 19.01.2023

10 January, 2023

The Meeting of the Tariffs Council No. 1/2023 of 12.01.2023

23 December, 2022

Communication on the Tariff Council meeting on 22 December 2022

23 September, 2022

The Meeting of the Tariffs Council No. 24/2022 of 29.09.2022

02 August, 2022

The Meeting of the Tariffs Council No. 19/2022 of 11.08.2022

28 June, 2022

Communication on the meeting of the Tariff Council on 23 and 24 June 2022

30 March, 2022

Tariff Council meeting 6/2022 on 31.03.2022

Home page

News Publications Publikacje BIP

#webinar agenda Aktualności azathioprinum Bimzelx Collegium AOTMiT colorectal cancer communication Communication from the Transparency Council Communication on the Tariff Council Cost Accounting Standard Council for Tariffs Affairs covering neonatal care cyclophosphamidum Data acquisition dental treatment services diseases of the organ of vision drug programme Empliciti entecavirum etanercept Fycompa gastroscopy glaucoma health policy program health policy programme health policy programme on breast cancer health policy programme on infertility treatment Health Policy Programmes Impavido in vitro Inovelon Jardiance Meeting of the Transparency Council methotrexatum Milupa Basic-P minimum wage increases mycophenolate mofetil new new tariffs news Notice Notice of the President Ontozry Onureg Opdivo Opdivo (nivolumab)opinion Opinion of the President Opinion of the Transparency Council Ospolot Ozurdex perinatal care Ponvory Position of the Transparency Council Press conference Recommendation Recommendation of the President Renastep report Rezurock sirolimus Suliqua Tariff Council Tariffs Council tenofovirum disoproxilum the drug programme B.44 the drug programme B.82 The Meeting of the Tariffs Council trainings Transparency Council Tremfya update Vivitrol Yervoy